Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
Vera Grinkevitch(Wellcome Sanger Institute), Simon S. McDade(Queen's University Belfast)
Research Portal (Queen's University Belfast)
April 1, 2022
Cited by 3
Related Papers
Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer
|Cancer Research|2017|235
Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with Dasatinib
|Molecular Cancer Therapeutics|2016|85
A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence
|Genes & Development|2015|40
Dying to Survive—The p53 Paradox
|Cancers|2021|37
FLIP(L) determines p53 induced life or death
|bioRxiv (Cold Spring Harbor Laboratory)|2019|0